Literature DB >> 3157737

Exercise systolic blood pressure: a powerful determinant of increased left ventricular mass in patients with hypertension.

J F Ren, A H Hakki, M N Kotler, A S Iskandrian.   

Abstract

This study examines the relation between left ventricular mass determined by two-dimensional echocardiography and exercise blood pressure in patients with hypertension. Sixty-seven patients with hypertension and 19 normal subjects underwent treadmill exercise testing and two-dimensional echocardiography. The left ventricular mass index in the normal subjects was 80 +/- 10 g/m2 (mean +/- SD). Patients with hypertension were classified into two groups according to left ventricular mass: Group I (n = 42) had normal mass and Group II (n = 25) had increased mass (greater than 2 SD above the mean value in 19 normal subjects). There was a poor correlation between left ventricular mass and blood pressure at rest. However, a better correlation was found between left ventricular mass and exercise systolic blood pressure (r = 0.58, p less than 0.001) or the change in systolic blood pressure from rest to exercise (r = 0.48, p less than 0.001). Twenty-two (76%) of 29 patients with an exercise systolic blood pressure of 190 mm Hg or greater had an increased left ventricular mass index, whereas only 3 (8%) of 38 patients with an exercise systolic blood pressure of less than 190 mm Hg had an increased left ventricular mass index (p less than 0.0001). Thus, in patients with hypertension, left ventricular mass index is poorly related to blood pressure at rest, but is related to exercise systolic blood pressure. Patients with an exercise systolic blood pressure of 190 mm Hg or greater usually have an increased left ventricular mass. These findings may have therapeutic implications.

Entities:  

Mesh:

Year:  1985        PMID: 3157737     DOI: 10.1016/s0735-1097(85)80029-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Ergometry as a basis for judging the antihypertensive effect.

Authors:  I W Franz; U Tönnesmann; D Erb; R Ketelhut
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  A case of hypertension.

Authors:  P D Gerber
Journal:  J Gen Intern Med       Date:  1996-04       Impact factor: 5.128

3.  Regression of left ventricular hypertrophy by acebutolol and nifedipine.

Authors:  I W Franz; U Tönnesmann; U Behr; R Ketelhut
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

4.  Left ventricular mass and diastolic function in obese children and adolescents.

Authors:  Paripović Dušan; Ilisić Tamara; Vukomanović Goran; Miloševski-Lomić Gordana; Peco-Antić Amira
Journal:  Pediatr Nephrol       Date:  2014-10-30       Impact factor: 3.714

5.  Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome.

Authors:  Laura De Petris; Alessandra Gianviti; Ugo Giordano; Armando Calzolari; Alberto E Tozzi; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2004-11       Impact factor: 3.714

6.  Correlative factors of left ventricular hypertrophy in end-stage renal disease.

Authors:  Y Dai; S J He; Y Yu; L Y Zhu; B Peng; J B Liu; S C Tang
Journal:  J Tongji Med Univ       Date:  1993

Review 7.  Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy.

Authors:  C Morisco; L Argenziano; N Tozzi; A F Mele; B Ricciardelli; G Condorelli; B Trimarco
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Effect of beta-blockade on exercise capacity in hypertensive subjects: a one-year double-blind study of celiprolol and metoprolol.

Authors:  G P Vyssoulis; M T Kouremetis; M A Valiouli; A P Michaelides; P K Toutouzas
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

9.  Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham Heart Study.

Authors:  George Thanassoulis; Asya Lyass; Emelia J Benjamin; Martin G Larson; Joseph A Vita; Daniel Levy; Naomi M Hamburg; Michael E Widlansky; Christopher J O'Donnell; Gary F Mitchell; Ramachandran S Vasan
Journal:  Circulation       Date:  2012-05-09       Impact factor: 29.690

Review 10.  Exercise Hypertension.

Authors:  Martin G Schultz; James E Sharman
Journal:  Pulse (Basel)       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.